Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Advancements study found that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://marcellem269gpy3.signalwiki.com/user